Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. UCN-01 may increase the effectiveness of a chemotherapy drug by
making tumor cells more sensitive to the drug.
PURPOSE: Phase I trial to study the effectiveness of fluorouracil plus UCN-01 in treating
patients who have advanced or refractory solid tumors.